Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-45,866
Closed -$960K 95
2025
Q2
$960K Sell
45,866
-2,917
-6% -$66.3K 0.52% 48
2025
Q1
$1.17M Sell
48,783
-9,802
-17% -$217K 0.65% 44
2024
Q4
$1.25M Sell
58,585
-2,641
-4% -$59.9K 0.66% 43
2024
Q3
$1.42M Buy
61,226
+173
+0.3% +$3.58K 0.72% 45
2024
Q2
$1.11M Buy
61,053
+22,120
+57% +$429K 0.6% 50
2024
Q1
$836K Buy
38,933
+6,566
+20% +$133K 0.43% 56
2023
Q4
$697K Sell
32,367
-15,608
-33% -$312K 0.38% 55
2023
Q3
$963K Buy
47,975
+4,575
+11% +$106K 0.58% 49
2023
Q2
$1.15M Buy
+43,400
New +$1.13M 0.65% 46

Other funds holding KVUE

Lipe & Dalton's KVUE Position: Q3 2025 in Review

Lipe & Dalton sold out of Kenvue (KVUE) in Q3 2025, closing a stake of 45,866 shares — an estimated $960K sold.

Lipe & Dalton first reported a position in KVUE in Q2 2023 and held it in 9 quarters. The position peaked at $1.42M in Q3 2024. 1,064 funds tracked by Wall St. Rank hold KVUE as of Q3 2025.

  • Lipe & Dalton reported no remaining Kenvue position as of Q3 2025 after selling out during the quarter.
  • Lipe & Dalton sold 45,866 Kenvue shares in Q3 2025, an estimated $960K.
  • Lipe & Dalton first reported a position in Kenvue in Q2 2023 and held it in 9 quarters.
  • Lipe & Dalton's Kenvue position peaked at $1.42M in Q3 2024.
  • 1,064 funds tracked by Wall St. Rank held Kenvue as of Q3 2025.

Based on Lipe & Dalton's 13F filing for Q3 2025, filed 26 Jan 2026.